| scholarly article | Q13442814 |
| review article | Q7318358 |
| P921 | main subject | malaria | Q12156 |
| World Health Organization | Q7817 | ||
| P304 | page(s) | 1-65 | |
| P577 | publication date | 1990-01-01 | |
| P1433 | published in | Transactions of the Royal Society of Tropical Medicine and Hygiene | Q15766916 |
| P1476 | title | Severe and complicated malaria. World Health Organization, Division of Control of Tropical Diseases | |
| P478 | volume | 84 Suppl 2 |
| Q40643743 | A CLINICAL STUDY OF FALCIPARUM MALARIA - 302 CASES. |
| Q39211638 | A Toll-like receptor-1 variant and its characteristic cellular phenotype is associated with severe malaria in Papua New Guinean children. |
| Q57804490 | A biomarker approach to syndrome-based treatment of severe childhood illness in malaria-endemic areas |
| Q48022213 | A case of blackwater fever with persistent Plasmodium falciparum parasitaemia detected by PCR after artemether-lumefantrine treatment |
| Q36604263 | A clinicopathological correlation of the expression of the angiopoietin-Tie-2 receptor pathway in the brain of adults with Plasmodium falciparum malaria |
| Q28365926 | A comparison of oral artesunate and artemether antimalarial bioactivities in acute falciparum malaria |
| Q24814579 | A randomized trial of artemether-lumefantrine versus mefloquine-artesunate for the treatment of uncomplicated multi-drug resistant Plasmodium falciparum on the western border of Thailand |
| Q39150398 | Absorption of intramuscular phenobarbitone in children with severe falciparum malaria |
| Q37121012 | Activities of artesunate and primaquine against asexual- and sexual-stage parasites in falciparum malaria |
| Q39125017 | Admission diagnosis of cerebral malaria in adults in an endemic area of Tanzania: implications and clinical description |
| Q34937320 | Adverse effect of rifampin on quinine efficacy in uncomplicated falciparum malaria |
| Q33765361 | Age-related buildup of humoral immunity against epitopes for rosette formation and agglutination in African areas of malaria endemicity |
| Q34326937 | Allelic heterogeneity of G6PD deficiency in West Africa and severe malaria susceptibility |
| Q33419466 | An autochthonous case of severe Plasmodium knowlesi malaria in Thailand |
| Q35048008 | Antigen-driven focal inflammatory death of malaria liver stages |
| Q33979153 | Antimalarial bioavailability and disposition of artesunate in acute falciparum malaria |
| Q36693763 | Antipyretic effect of ibuprofen in Gabonese children with uncomplicated falciparum malaria: a randomized, double-blind, placebo-controlled trial |
| Q28192467 | Antipyretics in children |
| Q34230161 | Artemether bioavailability after oral or intramuscular administration in uncomplicated falciparum malaria |
| Q34114331 | Artemisinin derivatives versus quinine for cerebral malaria in African children: a systematic review |
| Q35803021 | Artemisinin population pharmacokinetics in children and adults with uncomplicated falciparum malaria |
| Q24630683 | Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial |
| Q33754684 | Arthropod borne disease: the leading cause of fever in pregnancy on the Thai-Burmese border |
| Q34116823 | Association of a determinant on mouse chromosome 18 with experimental severe Plasmodium berghei malaria |
| Q90028524 | Associations Between Restrictive Fluid Management and Renal Function and Tissue Perfusion in Adults With Severe Falciparum Malaria: A Prospective Observational Study |
| Q37699693 | Blackwater fever in an uncomplicated Plasmodium falciparum patient treated with dihydroartemisinin-piperaquine |
| Q40263779 | Blackwater fever like in murine malaria |
| Q34001952 | Blood mononuclear cell nitric oxide production and plasma cytokine levels in healthy gabonese children with prior mild or severe malaria |
| Q33909219 | Blood transfusion for treating malarial anaemia |
| Q36829217 | Burden, features, and outcome of neurological involvement in acute falciparum malaria in Kenyan children |
| Q34407989 | Candidate polymorphisms and severe malaria in a Malian population |
| Q43982738 | Cerebral malaria is associated with low levels of circulating endothelial progenitor cells in African children |
| Q33426858 | Characteristics of Travel-Related Severe Plasmodium vivax and Plasmodium falciparum Malaria in Individuals Hospitalized at a Tertiary Referral Center in Lima, Peru. |
| Q35091391 | Clinical features and outcome in children with severe Plasmodium falciparum malaria: a meta-analysis |
| Q36035590 | Clinical illness and outcomes in Nigerian children with late-appearing anaemia after artemisinin-based combination treatments of uncomplicated falciparum malaria |
| Q37133868 | Common variation in the ABO glycosyltransferase is associated with susceptibility to severe Plasmodium falciparum malaria |
| Q33413521 | Comparison of imported Plasmodium ovale curtisi and P. ovale wallikeri infections among patients in Spain, 2005-2011. |
| Q34106127 | Comparison of oral artesunate and dihydroartemisinin antimalarial bioavailabilities in acute falciparum malaria |
| Q37253603 | Cytokine profiles and antibody responses to Plasmodium falciparum malaria infection in individuals living in Ibadan, southwest Nigeria. |
| Q21033622 | Decorticate, decerebrate and opisthotonic posturing and seizures in Kenyan children with cerebral malaria |
| Q43112579 | Definition of hyperparasitemia in severe falciparum malaria should be updated |
| Q37993739 | Dendritic cells and the malaria pre-erythrocytic stage |
| Q36265393 | Early rising asexual parasitaemia in Nigerian children following a first dose of artemisinin-based combination treatments of falciparum malaria |
| Q47339986 | Effect of dose size on the pharmacokinetics of orally administered quinine |
| Q36292400 | Effect of vitamin A adjunct therapy for cerebral malaria in children admitted to Mulago hospital: a randomized controlled trial |
| Q35216937 | Effects of malaria parasite density on blood cell parameters |
| Q33578904 | Elevated levels of vascular endothelial growth factor (VEGF) and soluble vascular endothelial growth factor receptor (VEGFR)-2 in human malaria |
| Q36880389 | Epidemiology, pathophysiology, management and outcome of renal dysfunction associated with plasmodia infection. |
| Q24814830 | Estimation of the total parasite biomass in acute falciparum malaria from plasma PfHRP2 |
| Q35347186 | Evaluation of liver function in severe malaria in children under five in Kinshasa, Democratic Republic of the Congo |
| Q24535657 | Evolutionary and historical aspects of the burden of malaria |
| Q40431077 | Fever and shock in a child: How 'good' is a good blood test? |
| Q36684103 | Genetic diversity of Plasmodium falciparum infections in mild and severe malaria of children from Kampala, Uganda |
| Q35037366 | Genetic factors associated with development of cerebral malaria and fibrotic schistosomiasis |
| Q36114619 | Haemoglobinopathies and the clinical epidemiology of malaria: a systematic review and meta-analysis |
| Q33412434 | Hematological Parameters in Severe Complicated Plasmodium falciparum Malaria among Adults in Aden |
| Q24246611 | High first dose quinine regimen for treating severe malaria |
| Q36980656 | Hospitalization and ambulatory care in imported-malaria: evaluation of trends and impact on mortality. A prospective multicentric 14-year observational study |
| Q34480040 | ICU management of severe malaria |
| Q38928387 | Immunoglobulin G isotype responses to variant surface antigens of Plasmodium falciparum in healthy Gabonese adults and children during and after successive malaria attacks |
| Q37327847 | Imported malaria in Korea: a 13-year experience in a single center |
| Q33294900 | Improving case definitions for severe malaria |
| Q24802371 | Increased fluidity and oxidation of malarial lipoproteins: relation with severity and induction of endothelial expression of adhesion molecules |
| Q33324482 | Increased microerythrocyte count in homozygous alpha(+)-thalassaemia contributes to protection against severe malarial anaemia |
| Q24245881 | Intramuscular arteether for treating severe malaria |
| Q37726740 | Intravenous artesunate versus intravenous quinine in the treatment of severe falciparum malaria: a retrospective evaluation from a UK centre |
| Q39665183 | Microsatellite characterization of Plasmodium falciparum from cerebral and uncomplicated malaria patients in southern Vietnam |
| Q37730159 | Oligohydramnios in a pregnant Pakistani woman with Plasmodium vivax malaria |
| Q40298270 | Outcome and prognostic factors of malaria-associated acute kidney injury requiring hemodialysis: A single center experience |
| Q36842213 | Pharmacokinetic properties of intramuscular versus oral syrup paracetamol in Plasmodium falciparum malaria |
| Q35802479 | Pharmacokinetics of intramuscular artemether in patients with severe falciparum malaria with or without acute renal failure |
| Q33976068 | Pharmacokinetics of mefloquine combined with artesunate in children with acute falciparum malaria. |
| Q41292997 | Pharmacokinetics of quinine, chloroquine and amodiaquine. Clinical implications |
| Q35822120 | Plasmodium berghei ANKA causes intestinal malaria associated with dysbiosis |
| Q36558387 | Population pharmacokinetic and pharmacodynamic properties of intramuscular quinine in Tanzanian children with severe Falciparum malaria |
| Q37239877 | Positive selection of a CD36 nonsense variant in sub-saharan Africa, but no association with severe malaria phenotypes |
| Q36173275 | Possible association of the Plasmodium falciparum T1526C resa2 gene mutation with severe malaria |
| Q35659570 | Prediction of outcome in adults with severe falciparum malaria: a new scoring system |
| Q34201314 | Prediction of outcome of severe falciparum malaria in Koraput, Odisha, India: A hospital-based study |
| Q37014184 | Prognostic indicators in adults hospitalized with falciparum malaria in Western Thailand |
| Q39370925 | Quinine pharmacokinetic-pharmacodynamic relationships in uncomplicated falciparum malaria |
| Q33690621 | Randomized comparison of artemether-benflumetol and artesunate-mefloquine in treatment of multidrug-resistant falciparum malaria. |
| Q40535234 | Randomized control trial of quinine and artesunate in complicated malaria |
| Q37685454 | Relationship of regulatory T cells to Plasmodium falciparum malaria symptomatology in a hypoendemic region. |
| Q37048131 | Resistant Malaria : Current Concepts and Therapeutic Strategies |
| Q38672428 | Respiratory Complications of Plasmodium vivax Malaria: Systematic Review and Meta-Analysis |
| Q34044042 | Risk factors for Plasmodium falciparum hyperparasitaemia in malarious children |
| Q33557414 | Role of Coma Acidosis Malaria Score in Patients with Severe Malaria among Indian Population: a Tertiary Care Center Experience |
| Q36934549 | Role of Serum Lactate and Malarial Retinopathy in Prognosis and Outcome of Falciparum and Vivax Cerebral Malaria: A Prospective Cohort Study in Adult Assamese Tribes |
| Q34699070 | Routine anticonvulsants for treating cerebral malaria. |
| Q41156186 | SPONTANEOUS RUPTURE OF SPLEEN. |
| Q48033171 | Serum laminin and basic fibroblast growth factor concentrations in patients with complicated Plasmodium falciparum malaria |
| Q79843732 | Severe falciparum malaria |
| Q33377266 | Severe falciparum malaria (21 cases) |
| Q35946438 | Severe falciparum malaria in young children of the Kassena-Nankana district of northern Ghana |
| Q35876697 | Severe imported Plasmodium falciparum malaria, France, 1996-2003. |
| Q33719342 | Severe imported falciparum malaria: a cohort study in 400 critically ill adults |
| Q33400452 | Severe imported malaria in an intensive care unit: a review of 59 cases |
| Q46171361 | Severe malaria in African adults living in a seasonal endemic area |
| Q24632966 | Sickle cell trait and the risk of Plasmodium falciparum malaria and other childhood diseases |
| Q35590756 | Sociocultural and structural factors contributing to delays in treatment for children with severe malaria: a qualitative study in southwestern Uganda |
| Q41436125 | Successful oral therapy for severe falciparum malaria: the World Health Organization criteria revisited |
| Q28551039 | The Safety of a Conservative Fluid Replacement Strategy in Adults Hospitalised with Malaria |
| Q49936925 | The burden of presumed tuberculosis in hospitalized children in a resource-limited setting in Papua New Guinea: a prospective observational study. |
| Q33422287 | The clinical implications of thrombocytopenia in adults with severe falciparum malaria: a retrospective analysis |
| Q37346189 | The neurological assessment in young children treated with artesunate monotherapy or artesunate-mefloquine combination therapy for uncomplicated Plasmodium falciparum malaria |
| Q39030914 | The pattern of bacteraemia in children with severe malaria |
| Q33526349 | The relationship between anti-merozoite antibodies and incidence of Plasmodium falciparum malaria: A systematic review and meta-analysis |
| Q33980472 | Therapeutic responses to quinine and clindamycin in multidrug-resistant falciparum malaria |
| Q21033441 | Total and functional parasite specific IgE responses in Plasmodium falciparum-infected patients exhibiting different clinical status |
| Q56424272 | Treatment of adults with acute uncomplicated malaria with azithromycin and chloroquine in India, Colombia, and Suriname |
| Q42111238 | Tumor necrosis factor and lymphotoxin-alpha polymorphisms and severe malaria in African populations |
| Q43160152 | Variation in the ICAM1 gene is not associated with severe malaria phenotypes |
| Q35811289 | α2-Macroglobulin Can Crosslink Multiple Plasmodium falciparum Erythrocyte Membrane Protein 1 (PfEMP1) Molecules and May Facilitate Adhesion of Parasitized Erythrocytes |
Search more.